Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A2 | O00482 | 2/20 | 0.83 |
| ▸ | NR5A1 | Q13285 | 2/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.83 |
| ▸ | MAPT | P10636 | 1/20 | 0.74 |
| ▸ | RECQL | P46063 | 1/20 | 0.66 |
| ▸ | FABP3 | P05413 | 1/20 | 0.66 |
| ▸ | SELP | P16109 | 1/20 | 0.61 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.56 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.56 |
| ▸ | PTAFR | P25105 | 1/20 | 0.56 |
| ▸ | HTR1D | P28221 | 1/20 | 0.56 |
| ▸ | HTR2C | P28335 | 1/20 | 0.56 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.56 |
| ▸ | DRD3 | P35462 | 1/20 | 0.56 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.56 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.55 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.55 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.55 |
| ▸ | PRKCA | P17252 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31276170 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL10498201 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL31084795 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL4182988 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL234615 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL23834444 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL3730490 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL233018 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL25777 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL31695681 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118800338-B | Glycerol phospholipid marker for wild and cultivated bighead carp and application thereof | 中国水产科学研究院长江水产研究所 | 2025-04-15 | — | — | CN | claimed |
| CN-115840050-B | Use of a reagent for detecting a metabolic marker in the preparation of a sleep disorder screening or diagnosis product | 四川大学 | 2024-12-20 | — | — | CN | claimed |
| CN-118800338-A | Glycerol phospholipid marker for wild and cultivated bighead carp and application thereof | 中国水产科学研究院长江水产研究所 | 2024-10-18 | — | — | CN | claimed |
| CN-113138274-B | Composition, application and lung cancer patient diagnosis kit | 中国科学院大连化学物理研究所 | 2022-11-29 | — | — | CN | claimed |
| CN-114895018-A | Application of product for detecting metabolite level in serum in preparation of preparation for diagnosing various SLE patients and preparation | 中南大学湘雅二医院 | 2022-08-12 | — | — | CN | claimed |
| WO-2025235969-A2 | METHODS OF TREATMENT USING BIOMARKER-GUIDED PLASMAPHERESIS | CIRCULATE HEALTH, INC. (US) | 2025-11-13 | — | — | WO | disclosed |
| US-20250319190-A1 | APOE LIPOPROTEIN SYSTEMS | KISBEE THERAPEUTICS INC (US) | 2025-10-16 | — | — | US | disclosed |
| US-20250264481-A1 | METHODS FOR PREDICTION AND EARLY DETECTION OF DIABETES | Baker Heart and Diabetes Institute (AU) | 2025-08-21 | — | — | US | disclosed |
| US-12313634-B2 | Methods for prediction and early detection of diabetes | ZORA BIOSCIENCES OY (FI) | 2025-05-27 | — | — | US | disclosed |
| US-20250166821-A1 | METHODS FOR PREDICTION OF TREATMENT RESPONSE IN NON-ALCOHOLIC FATTY LIVER DISEASE | SAGIMET BIOSCIENCES INC. | 2025-05-22 | — | — | US | disclosed |
| US-12280114-B2 | Extraction of plant source “medicinal soup” and manual preparation of “herbal medicine” and related products | INSTITUTE OF BASIC MEDICAL SCIENCES (CN) | 2025-04-22 | — | — | US | disclosed |
| CN-118800338-B | Glycerol phospholipid marker for wild and cultivated bighead carp and application thereof | 中国水产科学研究院长江水产研究所 | 2025-04-15 | — | — | CN | disclosed |
| CN-113484518-B | Diagnostic biomarker for distinguishing lung diseases | 天津中医药大学 | 2023-11-03 | — | — | CN | disclosed |
| EP-3775906-B1 | METABOLITE-BASED BREAST CANCER DETECTION AND DIAGNOSIS | BURWINKEL BARBARA (DE) | 2023-08-30 | — | — | EP | disclosed |
| US-20230266329-A1 | NANOPARTICLES AND DISTINCT EXOSOME SUBSETS FOR DETECTION AND TREATMENT OF CANCER | UNIV CORNELL (US) | 2023-08-24 | — | — | US | disclosed |
| CN-113138274-B | Composition, application and lung cancer patient diagnosis kit | 中国科学院大连化学物理研究所 | 2022-11-29 | — | — | CN | disclosed |
| WO-2022236131-A1 | SERUM METABOLOMICS RELATED TO CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-11-10 | — | — | WO | disclosed |
| CN-114895018-A | Application of product for detecting metabolite level in serum in preparation of preparation for diagnosing various SLE patients and preparation | 中南大学湘雅二医院 | 2022-08-12 | — | — | CN | disclosed |
| US-20220087964-A1 | MATERNAL DPA FOR BENEFIT OF MOTHER AND/OR CHILD'S MENTAL HEALTH | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (A*STAR) (SG) | 2022-03-24 | — | — | US | disclosed |
| WO-2012143514-A1 | METHOD FOR THE DIAGNOSIS OF LIVER INJURY BASED ON A METABOLOMIC PROFILE | ASOCIACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA EN BIOCIENCIAS-CIC BIOGUNE (ES) | 2012-10-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250319190-A1 | APOE LIPOPROTEIN SYSTEMS | APOB, APOL1, LDLR | NR5A2 2095/4885NR5A1 3094/4885SMN1; SMN2 1150/4885 |
| US-12280114-B2 | Extraction of plant source “medicinal soup” and manual preparation of “herbal medicine” and related products | CHMP4B, FIP1L1, LIPC | NR5A2 3403/4885NR5A1 2662/4885SMN1; SMN2 3863/4885 |
| US-20250166821-A1 | METHODS FOR PREDICTION OF TREATMENT RESPONSE IN NON-ALCOHOLIC FATTY LIVER DISEASE | ACACB, ACACA, ACLY | NR5A2 2080/4885NR5A1 1779/4885SMN1; SMN2 3806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.